Long term antiviral suppression after treatment for neonatal herpes infection
- 1 April 2003
- journal article
- research article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 22 (4) , 371-372
- https://doi.org/10.1097/01.inf.0000064120.03600.cb
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Safety and Efficacy of High-Dose Intravenous Acyclovir in the Management of Neonatal Herpes Simplex Virus InfectionsPediatrics, 2001
- Application of the Polymerase Chain Reaction to the Diagnosis and Management of Neonatal Herpes Simplex Virus DiseaseThe Journal of Infectious Diseases, 1996
- Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a Phase I/II trialThe Pediatric Infectious Disease Journal, 1996
- Predictors of Morbidity and Mortality in Neonates with Herpes Simplex Virus InfectionsNew England Journal of Medicine, 1991
- A Controlled Trial Comparing Vidarabine with Acyclovir in Neonatal Herpes Simplex Virus InfectionNew England Journal of Medicine, 1991